ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $83,000 | -37.1% | 489 | 0.0% | 0.00% | – |
Q2 2022 | $132,000 | -51.8% | 489 | 0.0% | 0.00% | – |
Q1 2022 | $274,000 | -40.0% | 489 | -24.4% | 0.00% | – |
Q4 2021 | $457,000 | -61.2% | 647 | -10.4% | 0.00% | – |
Q3 2021 | $1,177,000 | -18.1% | 722 | 0.0% | 0.00% | – |
Q2 2021 | $1,437,000 | -87.0% | 722 | -78.4% | 0.00% | – |
Q1 2021 | $11,076,000 | -45.7% | 3,336 | -34.9% | 0.00% | – |
Q4 2020 | $20,394,000 | +19.6% | 5,124 | -20.9% | 0.00% | – |
Q3 2020 | $17,045,000 | +195.9% | 6,481 | +240.9% | 0.00% | – |
Q2 2020 | $5,760,000 | -62.3% | 1,901 | -75.6% | 0.00% | – |
Q1 2020 | $15,294,000 | -48.3% | 7,803 | +94.0% | 0.00% | – |
Q4 2019 | $29,602,000 | +80.9% | 4,022 | +11.1% | 0.00% | – |
Q3 2019 | $16,367,000 | -34.8% | 3,621 | +43.9% | 0.00% | – |
Q2 2019 | $25,085,000 | -54.1% | 2,516 | -46.2% | 0.00% | – |
Q1 2019 | $54,639,000 | +356.1% | 4,678 | +565.4% | 0.00% | – |
Q3 2018 | $11,979,000 | -0.2% | 703 | 0.0% | 0.00% | – |
Q2 2018 | $12,000,000 | – | 703 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,930,092 | $1,363,000 | 0.55% |
AMERICAN FINANCIAL GROUP INC | 1,480,000 | $1,045,000 | 0.29% |
Vanguard Capital Wealth Advisors | 158,900 | $111,000 | 0.08% |
Anson Funds Management LP | 553,652 | $391,000 | 0.04% |
Nantahala Capital Management | 894,659 | $632,000 | 0.02% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,479,000 | 0.02% |
Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831,000 | 0.02% |
Atom Investors LP | 113,151 | $80,000 | 0.01% |
Virtu Financial LLC | 130,270 | $91,000 | 0.01% |
Altshuler Shaham Ltd | 1,157,540 | $828,000 | 0.01% |